{"disease":{"id":"post-orthotopic-liver-transplantation","name":"post orthotopic liver transplantation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05355155","title":"Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03046901","title":"Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ochsner Health System","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}